Glycopeptide phosphonate derivatives

Details for Australian Patent Application No. 2001261107 (hide)

Owner Theravance, Inc.

Inventors Leadbetter, Michael R.; Linsell, Martin S.

Agent Davies Collison Cave

Pub. Number AU-B-2001261107

PCT Pub. Number WO01/98328

Priority 60213410 22.06.00 US

Filing date 1 May 2001

Wipo publication date 2 January 2002

Acceptance publication date 20 July 2006

International Classifications

C07K 9/00 (2006.01) Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

Event Publications

23 June 2005 Amendment Made

  The nature of the amendment is: Delete co-applicants Michael R. Leadbetter; Martin S. Linsell

20 July 2006 Application Accepted

  Published as AU-B-2001261107

16 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001261108-Liposome drug delivery

2001261106